Clinical Outcomes in Measurement-based Treatment (COMET): A trial of depression monitoring and feedback to primary care physicians

Depression and Anxiety

Volumn 29, Issue 10, 2012, Pages 865-873

  Yeung, Albert S ^a   Jing, Yonghua ^b   Brenneman, Susan K ^c   Chang, Trina E ^a   Baer, Lee ^a   Hebden, Tony ^b   Kalsekar, Iftekhar ^b   McQuade, Robert D ^d   Kurlander, Jonathan ^c   Siebenaler, Jean ^c   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c OPTUM   (United States)

^d OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

depressive disorder; primary health care; questionnaires; self report

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; TELECONSULTATION;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PHYSICIANS, PRIMARY CARE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867103260     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21983     Document Type: Article

References (53)

1. Centers for Disease Control and Prevention (CDC). Current depression among adults-United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep 2010; 59: 1229-1235.
2. American Psychiatric Association. Mood disorders. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). 4th ed. Arlington: American Psychiatric Publishing, Inc.; 2000.
3. Young AS, Klap R, Sherbourne CD, Wells KB,. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001; 58: 55-61.
4. Wang PS, Demler O, Olfson M, et al. Changing profiles of service sectors used for mental health care in the United States. Am J Psychiatry 2006; 163: 1187-1198.
5. Mojtabai R, Olfson M,. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. J Clin Psychiatry 2008; 69: 1064-1074.
6. Gelenberg AJ, Freeman MP, Markowitz JC, et al. APA Practice Guidelines: Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 3rd ed. American Psychiatry Association; 2010. Available at: http://www.psychiatryonline.com/pracGuide/PracticePDFs/PG-Depression3rdEd.pdf. Accessed January 6, 2011.
7. Institute for Clinical Systems Improvement. Health Care Guideline: Major Depression in Adults in Primary Care. 14th ed. ICSI; 2011. Available at: http://www.icsi.org/depression-5/depression-major-in-adults-in-primary-care-3. html. Accessed September 20, 2011.
8. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry 1999; 56: 1109-1115.
9. Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002; 288: 2836-2845.
10. Arroll B, Elley CR, Fishman T, et al. Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev 2009; CD007954.
11. Eyding D, Lelgemann M, Grouven U, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010; 341: c4737.
12. Lin EH, Katon WJ, Simon GE, et al. Low-intensity treatment of depression in primary care: is it problematic ? Gen Hosp Psychiatry 2000; 22: 78-83.
13. Rush AJ, Trivedi M, Carmody TJ, et al. One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies. Biol Psychiatry 2004; 56: 46-53.
14. Simon GE,. Long-term prognosis of depression in primary care. Bull World Health Organ 2000; 78: 439-445.
15. Corey-Lisle PK, Nash R, Stang P, Swindle R,. Response, partial response, and nonresponse in primary care treatment of depression. Arch Intern Med 2004; 164: 1197-1204.
16. Young AS, Klap R, Shoai R, Wells KB,. Persistent depression and anxiety in the United States: prevalence and quality of care. Psychiatr Serv 2008; 59: 1391-1398.
17. Petersen T, Papakostas GI, Mahal Y, et al. Psychosocial functioning in patients with treatment resistant depression. Eur Psychiatry 2004; 19: 196-201.
18. Greenberg P, Corey-Lisle PK, Birnbaum H, et al. Economic implications of treatment-resistant depression among employees. Pharmacoeconomics 2004; 22: 363-373.
19. Gibson TB, Jing Y, Smith CG, et al. Cost burden of treatment resistance in patients with depression. Am J Manag Care 2010; 16: 370-377.
20. Von, Korff M, Gruman J, Schaefer J, et al. Collaborative management of chronic illness. Ann Intern Med 1997; 127: 1097-1102.
21. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
22. Earle KA, Istepanian RS, Zitouni K, et al. Mobile telemonitoring for achieving tighter targets of blood pressure control in patients with complicated diabetes: a pilot study. Diabetes Technol Ther 2010; 12: 575-579.
23. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care 2009; 32: S13-S61.
24. Trivedi MH,. Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission. J Clin Psychiatry 2009; 70: 26-31.
25. Davidson JR,. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 2010; 71: e04.
26. National Institute for Health and Clinical Excellence. Depression: The Treatment and Management of Depression in Adults (NICE Clinical Guideline 90). NICE; 2009. Available at: http://www.nice.org.uk/nicemedia/live/12329/45888/ 45888.pdf. Accessed January 6, 2011.
27. Zimmerman M, McGlinchey JB,. Why don't psychiatrists use scales to measure outcome when treating depressed patients ? J Clin Psychiatry 2008; 69: 1916-1919.
28. Gilbody SM, House AO, Sheldon TA,. Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry 2002; 180: 101-103.
29. Gaynes BN, Rush AJ, Trivedi MH, et al. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D. J Gen Intern Med 2008; 23: 551-560.
30. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995; 273: 1026-1031.
31. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53: 924-932.
32. Klinkman MS, Bauroth S, Fedewa S, et al. Long-term clinical outcomes of care management for chronically depressed primary care patients: a report from the depression in primary care project. Ann Fam Med 2010; 8: 387-396.
33. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40.
34. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
35. Lowe B, Unutzer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 2004; 42: 1194-1201.
36. Oslin DW, Ross J, Sayers S, et al. Screening, assessment, and management of depression in VA primary care clinics. The Behavioral Health Laboratory. J Gen Intern Med 2006; 21: 46-50.
37. Health Insurance Portability and Accountability Act of 1996. Public Law 104-191, 104th Congress. US Department of Health & Human Services; 1996. Available at: http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAA Law.pdf. Accessed September 20, 2011.
38. International Epidemiological Association (IEA). Good Epidemiological Practice (GEP) IEA Guidelines for Proper Conduct in Epidemiologic Research. International Epidemiological Association website; 2007. Available at: http://ieaweb.org/2010/04/good-epidemiological-practice-gep/. Accessed July 11, 2012.
39. Pinto-Meza A, Serrano-Blanco A, Penarrubia MT, et al. Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone? J Gen Intern Med 2005; 20: 738-742.
40. Guy W,. ECDEU Assessment Manual for Psychopharmacology, Revised Version; Publication ADM 76-338. Bethesda, MD: US Department of Health, Education and Welfare; 1976.
41. Chandler GM, Iosifescu DV, Pollack MH, et al. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther 2010; 16: 322-325.
42. Fava M, Davidson KG,. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19: 179-200.
43. Chang TE, Jing Y, Yeung AS, et al. Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in Measurement-based Treatment (COMET) trial. Gen Hosp Psychiatry 2012; 34: 105-112.
44. Simon GE, VonKorff M, Rutter C, Wagner E,. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ 2000; 320: 550-554.
45. IMPACT. Evidence-Based Depression Care: Implementation. University of Washington, Department of Psychiatry & Behavioral Sciences; 2009. Available at: http://impact-uw.org/implementation/planning.html. Accessed January 21, 2011.
46. Williams MD, Jaeckels N, Rummans TA, et al. Creating value in depression management. Qual Prim Care 2010; 18: 327-333.
47. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010; 303: 47-53.
48. Trivedi MH, Rush AJ, Gaynes BN, et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology 2007; 32: 2479-2489.
49. Duffy FF, Chung H, Trivedi M, et al. Systematic use of patient-rated depression severity monitoring: is it helpful and feasible in clinical psychiatry? Psychiatr Serv 2008; 59: 1148-1154.
50. Craven MA, Bland R,. Better practices in collaborative mental health care: an analysis of the evidence base. Can J Psychiatry 2006; 51: 7S-72S.
51. Lesser IM, Leuchter AF, Trivedi MH, et al. Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatr Serv 2005; 56: 995-1004.
52. Gilmer WS, Trivedi MH, Rush AJ, et al. Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr Scand 2005; 112: 425-433.
53. Friedman ES, Wisniewski SR, Gilmer W, et al. Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. Depress Anxiety 2009; 26: 612-621.